Here’s a bold statement: the San Francisco Giants just made two moves that could quietly reshape their future—or fade into obscurity. But here’s where it gets controversial: are these signings a strategic play for depth, or a last-ditch effort to salvage talent? Let’s dive in.
Last month, the Giants inked infielder Buddy Kennedy and right-hander Caleb Kilian to minor league contracts, as confirmed by the team’s official transactions page. Both players had opted for minor league free agency after the season, but San Francisco saw something worth betting on. And this is the part most people miss: these aren’t just roster fillers—they’re players with unique stories and untapped potential.
Take Buddy Kennedy, for instance. Despite bouncing between the Phillies, Blue Jays, and Dodgers in 2025, he managed to appear in 13 big league games. His journey was anything but smooth—thanks to being out of minor league options, he faced a rollercoaster of designations, outrights, and waiver claims. But here’s the silver lining: no matter who won the World Series that year, Kennedy was guaranteed a ring. Talk about a consolation prize!
Kennedy’s major league stats (.178/.271/.274 over 181 plate appearances) might not jump off the page, but his minor league numbers (.281/.388/.429 with 33 homers in Triple-A) tell a different story. His real value? Defensive versatility. Kennedy’s experience at first, second, and third base—plus stints as a shortstop and left fielder—makes him a utility player worth watching. But here’s the catch: with the Giants’ infield nearly set (and rumors swirling around big names like Ketel Marte and Brendan Donovan), Kennedy’s path to playing time is anything but clear. Even if he doesn’t crack the roster, his out-of-options status could keep him in Triple-A as a depth piece.
Now, let’s talk Caleb Kilian. Drafted by the Giants in 2019, he was later traded to the Cubs in the Kris Bryant deal. His MLB debut? Underwhelming, with a 9.22 ERA and more walks than strikeouts in 27 1/3 innings. Injuries haven’t helped—a teres major strain sidelined him for half of 2024, and an undisclosed issue limited him to just 15 2/3 minor league innings in 2025. But here’s the twist: Kilian’s return to San Francisco could be his redemption arc. At 28, he’s still young enough to turn things around, and the Giants’ pitching development team is known for reviving careers. The question is: can he stay healthy long enough to prove his worth as a starter—or will he find a new role in the bullpen?
These signings might not grab headlines, but they’re a fascinating gamble. Kennedy’s versatility and Kilian’s untapped potential could pay off—or they could fade into the background. What do you think? Are these smart depth moves, or is the Giants’ front office grasping at straws? Let’s hear your take in the comments!
